Top compounds associated with response to RPS10


Feature Type Standardized
Nominal ANOVA
mRNA tivantinib CTRPv2 pan-cancer AAC 0.1 0.03
mRNA vorinostat:navitoclax (4:1 mol/mol) CTRPv2 pan-cancer AAC -0.082 0.03
mRNA CCT036477 CTRPv2 pan-cancer AAC -0.078 0.03
mRNA regorafenib CTRPv2 pan-cancer AAC 0.086 0.03
mRNA navitoclax:piperlongumine (1:1 mol/mol) CTRPv2 pan-cancer AAC -0.082 0.03
mRNA tacrolimus CTRPv2 pan-cancer AAC 0.082 0.03
mRNA Obatoclax Mesylate CTRPv2 pan-cancer AAC 0.077 0.03
mRNA foretinib CTRPv2 pan-cancer AAC 0.081 0.04
mRNA SB-743921 CTRPv2 pan-cancer AAC 0.074 0.04
mRNA KPT185 CTRPv2 pan-cancer AAC 0.085 0.04
Download CSV